The Valley Desk

NCT02030847 · Interventional trial

Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patients With Chemotherapy Resistant or Refractory Acute Lymphoblastic Leukemia

Overall registry status Completed

Phase 2

Conditions Patients With B Cell ALL, Relapsed or Refractory, With no Available Curative Treatment Options

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov